Newsroom

Sorted by: Latest

-

Addionics Launches Autonomous Architecture™, the Battery Design for the Always-On AI World

TEL AVIV, Israel--(BUSINESS WIRE)--Addionics, a pioneer in advanced battery architecture, today unveiled Addionics Autonomous Architecture™, a breakthrough smart battery architecture built for the always-on AI economy. As intelligent machines increasingly operate 24/7, the technology enables batteries to deliver higher performance, longer life, and greater efficiency under continuous, high-demand operations. It is designed for autonomous vehicles, robotics, satellites, drones, and next-generati...
-

Elucid Announces First Patient Enrollment in AI-PREDICT, a Landmark International Study to Define Lesion-Level Cardiovascular Risk

BOSTON--(BUSINESS WIRE)--Elucid, an innovator in AI-powered coronary CT angiography (CCTA) analysis, today announced first patient enrollment in AI-PREDICT, a retrospective, international, multicenter study designed to establish a new lesion-centric paradigm for cardiovascular risk stratification. Enrollment is underway at three of more than 20 planned sites across the U.S., Europe, and Asia: Emory University, the Medical University of South Carolina, and Centro Cardiologico Monzino, Milan, led...
-

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with prostate adenocarcinoma....
-

AccurKardia and Wellysis Sign Multi-Year Agreement to Provide Wellysis’ Turnkey Cardiac Monitoring Offering in the U.S. Market

NEW YORK & SEOUL--(BUSINESS WIRE)--AccurKardia, Inc., an ECG-led diagnostics software company, and Wellysis, a digital healthcare company and developer of the S-Patch wearable ECG monitor, today announced a multi-year agreement under which AccurKardia’s AccurECG 2.0 will power the analytics behind Wellysis’ turnkey cardiac monitoring offering in the U.S. The agreement, which was signed last week in Seoul, is the latest between the two companies.Under the agreement, Wellysis’ S-Patch wearable dev...
-

Altasciences et Evidence Matters font progresser le développement de médicaments basé sur l'IA grâce à une avancée majeure en matière d'automatisation des essais précliniques

LAVAL, Québec--(BUSINESS WIRE)--Altasciences, une organisation entièrement intégrée spécialisée dans le développement de médicaments en phase précoce, et Evidence Matters, pionnier dans le domaine de la science des données issues des essais cliniques, ont le plaisir d’annoncer la réussite d’une démonstration de concept (POC) de RegulatoryFlow (« RegFlow »), suite à l’annonce de leur collaboration stratégique en août 2025. Cette validation de principe a démontré que les gains d’efficacité généré...
-

Half of Gen Z Workers Report AI Guilt Despite Rising Demand for AI Skills

LONDON--(BUSINESS WIRE)--A new workplace trend is emerging for Gen Z employees: “AI Guilt”, where younger workers increasingly see AI literacy as essential to their careers, but do not yet feel they have clear permission for using it openly at work. New data from Employment Hero, the global AI-powered employment platform, reveals that 50% of Gen Z workers feel guilty using AI to produce work, while 52% say using AI to do parts of their job feels like cheating. The data forms part of Employment...
-

$150 Million in C-PACE Financing Identified to Fund Completion of Regent Bank Amphitheater and Sunset Amphitheater at McKinney

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), owner, operator, and developer of premium live entertainment destinations, today announced that CBRE Group Inc. (NYSE: CBRE), retained by the Company to secure Commercial Property Assessed Clean Energy ("C-PACE") financing, has identified more than $150 million in gross proceeds for VENU®. C-PACE proceeds are expected to fully fund the balance of construction for Regent Bank Amphi...
-

IS $9.50 PER SHARE FAIR FOR GBTG SHAREHOLDERS? Kaskela Law is Investigating the Looming Shareholder Buyout and Encourages Investors to Contact the Firm Today to Discuss their Rights and Options

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Investor protection law firm Kaskela Law is investigating the Global Business Travel Group, Inc. (NYSE: GBTG) (“GBTG”) shareholder buyout to determine whether the transaction as structured is fair and provides investors with a sufficient price for their GBTG shares. Click here for additional information: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, GBTG announced that it had agreed to be privatized at a price of $9.50 per share...
-

Builders FirstSource to Host Second Quarter 2026 Financial Results Conference Call and Webcast

IRVING, Texas--(BUSINESS WIRE)--Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource” or the "Company") will host a conference call and webcast on Thursday, July 30, 2026, to discuss the Company’s financial results and other business matters. The teleconference will begin at 8:00 a.m. Central Time and will be hosted by Peter Jackson, President and Chief Executive Officer, and Pete Beckmann, Chief Financial Officer. The live webcast, archived replay, and the accompanying presentation c...
-

United Natural Foods Announces Leadership Updates to Accelerate Value Creation Strategy

PROVIDENCE, R.I.--(BUSINESS WIRE)--United Natural Foods, Inc. (NYSE: UNFI) (the “Company” or “UNFI”) today announced leadership updates to strengthen execution of the Company’s strategy, focused on adding value for customers and suppliers while improving effectiveness and efficiency. These updates, effective August 3, 2026, are designed to align UNFI’s leadership structure more closely with its strategy, helping the Company accelerate capability building, sharpen operational execution, and cont...